Bioscience Pharma Competitors and Similar CompaniesClear all
Chugai Pharmaceutical's competitors and similar companies include Symphogen and Immunomedics.
 Chugai Pharmaceutical Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | ||
Founding Date | Founding Date 1925 | Founding Date 2000 | Founding Date 1982 |
Type | Type Public | Type Private | Type Subsidiary |
Tags | |||
Locations | Locations Chuo City, JP HQ Guangzhou Shi, CN Taizhou, CN Puteaux, FR Frankfurt Am Main, DE Singapore, SG see more | Locations Ballerup, DK HQ Somerville, US | Locations Morris Plains, US HQ |
Employees | Employees 7,778 | Employees 196 | Employees 8914% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.3t (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $295k (FY, 2019) |
Cost of goods | Cost of goods ¥363.7b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥903.5b (FY, 2025) | Gross profit N/A | Gross profit $295k (FY, 2019) |
Net income | Net income ¥434b (FY, 2025) | Net income N/A | Net income ($357.3m) (FY, 2019) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 387.2m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Symphogen
HQ
Ballerup, DK
Employees
196
Symphogen is a biotech company focused on oncology and immuno-oncology.
View companyImmunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company